Clinical trial
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation…
NCT00126555 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00126555 |
|---|---|
| Title | Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer |
| Official title | A Phase II Study of ZD1839 and Radiation in Patients With Squamous Cell Carcinoma of the Skin |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin |
| Intervention type | Drug, Other, Procedure, Radiation |
| Interventions | Gefitinib, Radiotherapy, Conventional surgery, laboratory biomarker analysis |
| Enrollment | 23 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 1, 2013 |
| Completion | Feb 1, 2013 |
| First posted | Aug 4, 2005 |
| Last update posted | Aug 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: